The pharmacokinetic interaction is absent, the pharmacodynamic interaction is dose-dependent, and 300 mg/day falls below the threshold where thyroid or significant glucose effects have been consistently documented
[Schedule a consultation](/contact) to learn more
Thus, oxidative damage in depression and anxiety disorders can affect the amygdala and hippocampus (Salim, 2017), among other brain structures, reduce neurogenesis (van Velzen et al., 2017), and contribute to cognitive dysfunction (Lindqvist et al., 2017), such as proinflammatory cytokines (Slavich et al., 2020)
The current standard of care for patients with DS includes little to none of the information offered in this article
Wiley-Blackwell 111 River St, Hoboken 07030-5774, NJ USA